P53-Dependent and Independent Expression of P21 During Cell Growth, Differentiation, and DNA Damage

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Downloaded from genesdev.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press p53-Dependent and independent expression of p21 during cell growth, differentiation, and DNA damage Kay F. Macleod, 1 Nicole Sherry, 1 Greg Hannon, 2 David Beach, 2 Takashi Tokino, 3 Kenneth Kinzler, 3 Bert Vogelstein, 3 and Tyler Jacks L4 tHoward Hughes Medical Institute, Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 USA; 2Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 USA; 3The Oncology Center, The John Hopkins University School of Medicine, Baltimore, Maryland 21231 USA Expression of p21 has been shown to be up-regulated by the p53 tumor suppressor gene in vitro in response to DNA-damaging agents. However, p21 expression can be regulated independently of p53, and here we show that expression of p21 in various tissues during development and in the adult mouse occurs in the absence of p53 function. However, most tissues tested did require p53 for p21 induction following exposure of the whole animal to ~/irradiation. These results show that normal tissue expression of p21 to high levels is not dependent on p53 and confirm that induction of p21 by DNA-damaging agents does require p53. p21 is expressed upon differentiation of p53-deficient murine erythroleukemia (MEL1 cells, and the kinetics of induction of p21 in this system suggest that it may be involved in the growth arrest that precedes terminal differentiation. The gene is up-regulated in mouse fibroblasts in response to serum restimulation but the kinetics and levels of induction differ between wild-type and mutant cells. Expression of p21 message following serum restimulation is superinducible by cycloheximide in wild-type but not in p53-deficient cells. The increases in p21 mRNA are reflected in changes in p21 protein levels, p21 expression also appears to be regulated at the post-transcriptional level because moderate increases in mRNA expression, during differentiation of MEL cells and upon serum restimulation of fibroblasts, are followed by large increases in protein levels. Regulation of the mouse p21 promoter by p53 depends on two critical p53-binding sites located 1.95 and 2.85 kb upstream from the transcriptional initiation site. The sequences mediating serum responsiveness of the promoter map to a region containing the proximal p53 site. p53 appears to play a critical role in p21 induction following DNA damage. Moreover, p21 can be regulated independently of p53 in several situations including during normal tissue development, following serum stimulation, and during cellular differentiation. [Key Words: DNA damage; p53; p21~ cellular differentiation) Received January 27, 1995; revised version accepted March 3, 1995. Cell-cycle progression has been shown to be modulated cyclin/cdk inhibitor or as an assembly factor may de- by a new class of regulators known as cyclin kinase in- pend on the stoichiometry of components within these hibitors. The first of these proteins to be identified and complexes (Zhang et ah 19941, such that at low concen- cloned was p21, which is the product of the WAF- 1 / CIP 1 tration p21 may promote complex assembly, whereas at gene and is variously referred to as p21/WAF-1/CIP1 (E1- higher concentrations it might be inhibitory. Deiry et al. 1993; Harper et al. 1993; Xiong et al. p21 was cloned independently by virtue of its induc- 1993a, b). p21 forms a quaternary complex with cyclins, tion by p53 (E1-Deiry et al. 1993), its association with cyclin-dependent kinases (cdks), and proliferating cell cyclin/cdk complexes (Xiong et al. 1993b; Harper et al. nuclear antigen (PCNA)(Xiong et al. 1993a} and acts to 1993) and its up-regulation in senescent cells INoda et al regulate cyclin/cdk activity and to directly affect DNA 19941. Other cyclin/cdk inhibitors have since been iden- replication through its interaction with PCNA (Waga et tified and cloned (Serrano et al. 1993; Hannon and Black al. 1994; Li et al. 1994). p21 can promote cyclin/cdk 1994; Polyak et al. 1994), including p16 (Serrano et al. complex assembly in vitro (Zhang et al. 1994), and be- 19931 and p15 (Hannon and Black 19941, which appear to cause p21 exists in normal cycling cells, it may perform specifically inhibit cyclin D/cdk4 complexes, p16 is fre- this function in vivo as well. The role of p21 as either a quently mutated in a variety of tumors (Hussussian et al. 1994; Kamb et al. 1994a,b; Nobori et al. 1994). The p27 4Conesponding author. cyclin/cdk inhibitor is also involved in mediating GENES & DEVELOPMENT 9:935-944 91995 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/95 $5.00 935 Downloaded from genesdev.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press Macleod et al. growth arrest and inhibits cyclin E/cdk2 and cyclin These results suggest that regulation of expression of A/cdk2 complexes, p27 is induced in T cells in response p21 mRNA in normal mouse tissues occurs by a mech- to interleukin-2 and in the HL60 cell line in response to anism not involving p53. However, previous reports retinoic acid as these cells differentiate to form granulo- have clearly shown the importance of p53 in the induc- cytes (Polyak et al. 1994). However, only p21 has been tion of p21 following exposure to ionizing radiation and shown to affect DNA replication (Waga et al. 1994; Li et other DNA-damaging agents (Di Leonardo et al. 1994; al. 1994). E1-Deiry et al. 1994). Thus, we examined the pattern of p21 is up-regulated by p53 following DNA damage p21 expression in wild-type and mutant animals follow- (Xiong et al. 1993a, b; E1-Deiry et al. 1993, 1994; Di Le- ing ~/irradiation. As shown in Figure 1B, significant in- onardo et al. 1994) and is thought to be an integral part of duction of p21 occurs in all wild-type tissues examined, the p53-mediated growth-arrest pathway (E1-Deiry et al. except for the small intestine in which p21 expression is 1994). Regulation of p21 by p53 presumably occurs at the very high prior to irradiation. No induction of p21 level of transcriptional initiation because it is known mRNA was observed in tissues of irradiated p53-defi- that the ability of p53 to induce growth arrest requires its cient animals (Fig. 1B), confirming the importance of p53 trans-activation domain (Pietenpol et al. 1994). Also, in the irradiation response. loss of p53 results in dramatic reductions in p21 message Given the results with adult tissues, we next exam- levels (Xiong et al. 1993a; E1-Deiry et al. 1993, 1994). The ined p21 mRNA levels in tissues from wild-type and putative role of p21 in growth arrest mediated by p53 p53-/- embryos. Most embryonic cell types are still makes it an important gene with respect to the under- proliferating and the role of p21 in modulating cell-cycle standing of loss of growth control in transformation pro- progression may result in a different pattern of p21 ex- cesses. Mice that are homozygous for a targeted disrup- pression in embryonic tissues compared with adult tis- tion of the p53 gene are predisposed to tumor formation sues. As shown in Figure 1C, p21 is expressed in the but develop normally (Donehower et al. 1992; Jacks et al. carcass of wild-type embryos at 13.5 days of gestation 1994). Thus, either p21 itself is not essential for normal but not in fetal liver, brain, lungs, or heart. As was ob- development or p21 expression is not fully dependent on served in adult tissues, expression in embryonic carcass p53. is not dependent on p53 because high levels of expres- To characterize more fully the normal regulation of sion are also seen in p53-/- embryos (Fig. 1C). Quite p21, we have compared its expression in a variety of cells unexpectedly, absence of p53 actually resulted in in- and tissues with or without functional p53. We conclude creased expression of p21 in embryonic brain. that p21 expression during development and in the adult mouse can be p53-independent and that the gene can be induced by serum and upon differentiation in the ab- p21 mRNA and protein are induced during MEL sence of p53 function. However, p53 appears to be nec- cell differentiation essary for p21 induction following DNA damage, a func- Murine erythroleukemia (MEL) cells are derived from tion that may be critical for its tumor suppressor prop- erythoid tumors that develop in mice infected by the erties. Friend virus complex. These leukemic cells are growth- factor independent, carry activated forms of Ets family oncogenes, and are mutant for p53 (Ben-David and Bern- Results stein 1991). The cell line is effectively blocked in ery- p21 mRNA is expressed in various tissues throid differentiation and proliferates in culture until in- independently of p53 duced to terminally differentiate by various agents such as dimethylsulfoxide (DMSO)or N, N'-hexamethylene- Given the role of p21 in regulating cell-cycle progression bis-acetamide (HMBA). Alterations in the cell cycle of and DNA replication (Harper et al. 1993; Xiong et al. MEL cells following their induction to differentiate are 1993b; Li et al. 1994; Waga et al. 1994), we were inter- well characterized. Induction of differentiation in MEL ested in determining whether p21 expression was cells results in a prolonged G~ phase, up-regulated ex- strictly dependent on the presence of functional p53. Our pression of the retinoblastoma protein (Rb) tumor sup- initial studies focused on expression of p21 in tissues pressor gene, and increased levels of hypophosphorylated from wild-type and p53-deficient mice.
Recommended publications
  • CDK-Independent and PCNA-Dependent Functions of P21 in DNA Replication

    CDK-Independent and PCNA-Dependent Functions of P21 in DNA Replication

    G C A T T A C G G C A T genes Review CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication Sabrina Florencia Mansilla , María Belén De La Vega y, Nicolás Luis Calzetta y, Sebastián Omar Siri y and Vanesa Gottifredi * Cell Cycle and Genomic Stability Laboratory, Fundación Instituto Leloir, IIBBA-CONICET, Av. Patricias Argentinas 435, Buenos Aires 1405, Argentina; [email protected] (S.F.M.); [email protected] (M.B.D.L.V.); [email protected] (N.L.C.); [email protected] (S.O.S.) * Correspondence: [email protected] These authors contributed equally to this work. y Received: 9 April 2020; Accepted: 15 May 2020; Published: 28 May 2020 Abstract: p21Waf/CIP1 is a small unstructured protein that binds and inactivates cyclin-dependent kinases (CDKs). To this end, p21 levels increase following the activation of the p53 tumor suppressor. CDK inhibition by p21 triggers cell-cycle arrest in the G1 and G2 phases of the cell cycle. In the absence of exogenous insults causing replication stress, only residual p21 levels are prevalent that are insufficient to inhibit CDKs. However, research from different laboratories has demonstrated that these residual p21 levels in the S phase control DNA replication speed and origin firing to preserve genomic stability. Such an S-phase function of p21 depends fully on its ability to displace partners from chromatin-bound proliferating cell nuclear antigen (PCNA). Vice versa, PCNA also regulates p21 by preventing its upregulation in the S phase, even in the context of robust p21 induction by γ irradiation.
  • P14ARF Inhibits Human Glioblastoma–Induced Angiogenesis by Upregulating the Expression of TIMP3

    P14ARF Inhibits Human Glioblastoma–Induced Angiogenesis by Upregulating the Expression of TIMP3

    P14ARF inhibits human glioblastoma–induced angiogenesis by upregulating the expression of TIMP3 Abdessamad Zerrouqi, … , Daniel J. Brat, Erwin G. Van Meir J Clin Invest. 2012;122(4):1283-1295. https://doi.org/10.1172/JCI38596. Research Article Oncology Malignant gliomas are the most common and the most lethal primary brain tumors in adults. Among malignant gliomas, 60%–80% show loss of P14ARF tumor suppressor activity due to somatic alterations of the INK4A/ARF genetic locus. The tumor suppressor activity of P14ARF is in part a result of its ability to prevent the degradation of P53 by binding to and sequestering HDM2. However, the subsequent finding of P14ARF loss in conjunction with TP53 gene loss in some tumors suggests the protein may have other P53-independent tumor suppressor functions. Here, we report what we believe to be a novel tumor suppressor function for P14ARF as an inhibitor of tumor-induced angiogenesis. We found that P14ARF mediates antiangiogenic effects by upregulating expression of tissue inhibitor of metalloproteinase–3 (TIMP3) in a P53-independent fashion. Mechanistically, this regulation occurred at the gene transcription level and was controlled by HDM2-SP1 interplay, where P14ARF relieved a dominant negative interaction of HDM2 with SP1. P14ARF-induced expression of TIMP3 inhibited endothelial cell migration and vessel formation in response to angiogenic stimuli produced by cancer cells. The discovery of this angiogenesis regulatory pathway may provide new insights into P53-independent P14ARF tumor-suppressive mechanisms that have implications for the development of novel therapies directed at tumors and other diseases characterized by vascular pathology. Find the latest version: https://jci.me/38596/pdf Research article P14ARF inhibits human glioblastoma–induced angiogenesis by upregulating the expression of TIMP3 Abdessamad Zerrouqi,1 Beata Pyrzynska,1,2 Maria Febbraio,3 Daniel J.
  • Transcriptional Regulation of the P16 Tumor Suppressor Gene

    Transcriptional Regulation of the P16 Tumor Suppressor Gene

    ANTICANCER RESEARCH 35: 4397-4402 (2015) Review Transcriptional Regulation of the p16 Tumor Suppressor Gene YOJIRO KOTAKE, MADOKA NAEMURA, CHIHIRO MURASAKI, YASUTOSHI INOUE and HARUNA OKAMOTO Department of Biological and Environmental Chemistry, Faculty of Humanity-Oriented Science and Engineering, Kinki University, Fukuoka, Japan Abstract. The p16 tumor suppressor gene encodes a specifically bind to and inhibit the activity of cyclin-CDK specific inhibitor of cyclin-dependent kinase (CDK) 4 and 6 complexes, thus preventing G1-to-S progression (4, 5). and is found altered in a wide range of human cancers. p16 Among these CKIs, p16 plays a pivotal role in the regulation plays a pivotal role in tumor suppressor networks through of cellular senescence through inhibition of CDK4/6 activity inducing cellular senescence that acts as a barrier to (6, 7). Cellular senescence acts as a barrier to oncogenic cellular transformation by oncogenic signals. p16 protein is transformation induced by oncogenic signals, such as relatively stable and its expression is primary regulated by activating RAS mutations, and is achieved by accumulation transcriptional control. Polycomb group (PcG) proteins of p16 (Figure 1) (8-10). The loss of p16 function is, associate with the p16 locus in a long non-coding RNA, therefore, thought to lead to carcinogenesis. Indeed, many ANRIL-dependent manner, leading to repression of p16 studies have shown that the p16 gene is frequently mutated transcription. YB1, a transcription factor, also represses the or silenced in various human cancers (11-14). p16 transcription through direct association with its Although many studies have led to a deeper understanding promoter region.
  • Clusterin-Mediated Apoptosis Is Regulated by Adenomatous Polyposis Coli and Is P21 Dependent but P53 Independent

    Clusterin-Mediated Apoptosis Is Regulated by Adenomatous Polyposis Coli and Is P21 Dependent but P53 Independent

    [CANCER RESEARCH 64, 7412–7419, October 15, 2004] Clusterin-Mediated Apoptosis Is Regulated by Adenomatous Polyposis Coli and Is p21 Dependent but p53 Independent Tingan Chen,1 Joel Turner,1 Susan McCarthy,1 Maurizio Scaltriti,2 Saverio Bettuzzi,2 and Timothy J. Yeatman1 1Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; and 2Dipartimento di Medicina Sperimentale, Sezione di Biochimica, Biochimica Clinica e Biochimica dell’Esercizio Fisico, Parma, Italy ABSTRACT ptosis (15). Additional data suggest that a secreted form of clusterin acts as a molecular chaperone, scavenging denatured proteins outside Clusterin is a widely expressed glycoprotein that has been paradoxi- cells following specific stress-induced injury such as heat shock. cally observed to have both pro- and antiapoptotic functions. Recent Other data, show that overexpression of a specific nuclear form of reports suggest this apparent dichotomy of function may be related to two different isoforms, one secreted and cytoplasmic, the other nuclear. To clusterin acts as a prodeath signal (16). Furthermore, studies of human clarify the functional role of clusterin in regulating apoptosis, we exam- colon cancer suggest a conversion from the nuclear form of clusterin ined its expression in human colon cancer tissues and in human colon to the cytoplasmic form, which may promote tumor progression (17). cancer cell lines. We additionally explored its expression and activity using Recently, a link between the accumulation of the nuclear form of models of adenomatous polyposis coli (APC)- and chemotherapy-induced clusterin and anoikis induction in prostate epithelial cells was shown apoptosis. Clusterin RNA and protein levels were decreased in colon (18).
  • Complete Deletion of Apc Results in Severe Polyposis in Mice

    Complete Deletion of Apc Results in Severe Polyposis in Mice

    Oncogene (2010) 29, 1857–1864 & 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 $32.00 www.nature.com/onc SHORT COMMUNICATION Complete deletion of Apc results in severe polyposis in mice AF Cheung1, AM Carter1, KK Kostova1, JF Woodruff1, D Crowley1,2, RT Bronson3, KM Haigis4 and T Jacks1,2 1Koch Institute and Department of Biology, MIT, Cambridge, MA, USA; 2Howard Hughes Medical Institute, MIT, Cambridge, MA, USA; 3Department of Pathology, Tufts University School of Medicine and Veterinary Medicine, Boston, MA, USA and 4Masschusetts General Hospital Cancer Center, Harvard Medical School Department of Pathology, Charlestown, MA, USA The adenomatous polyposis coli (APC) gene product is region of APC termed the mutation cluster region and mutated in the vast majority of human colorectal cancers. result in retained expression of an N-terminal fragment APC negatively regulates the WNT pathway by aiding in of the APC protein (Kinzler and Vogelstein, 1996). the degradation of b-catenin, which is the transcription Genotype–phenotype correlations involving germline factor activated downstream of WNT signaling. APC APC mutations suggest that different lengths and levels mutations result in b-catenin stabilization and constitutive of APC expression can influence the number of polyps WNT pathway activation, leading to aberrant cellular in the gut, the distribution of polyps and extra-colonic proliferation. APC mutations associated with colorectal manifestations of the disease (Soravia et al., 1998; cancer commonly fall in a region of the gene termed the Nieuwenhuis and Vasen, 2007). Specifically, patients mutation cluster region and result in expression of an that present clinically with attenuated FAP have N-terminal fragment of the APC protein.
  • Loss of P21 Disrupts P14arf-Induced G1 Cell Cycle Arrest but Augments P14arf-Induced Apoptosis in Human Carcinoma Cells

    Loss of P21 Disrupts P14arf-Induced G1 Cell Cycle Arrest but Augments P14arf-Induced Apoptosis in Human Carcinoma Cells

    Oncogene (2005) 24, 4114–4128 & 2005 Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc Loss of p21 disrupts p14ARF-induced G1 cell cycle arrest but augments p14ARF-induced apoptosis in human carcinoma cells Philipp G Hemmati1,3, Guillaume Normand1,3, Berlinda Verdoodt1, Clarissa von Haefen1, Anne Hasenja¨ ger1, DilekGu¨ ner1, Jana Wendt1, Bernd Do¨ rken1,2 and Peter T Daniel*,1,2 1Department of Hematology, Oncology and Tumor Immunology, University Medical Center Charite´, Campus Berlin-Buch, Berlin-Buch, Germany; 2Max-Delbru¨ck-Center for Molecular Medicine, Berlin-Buch, Germany The human INK4a locus encodes two structurally p16INK4a and p14ARF (termed p19ARF in the mouse), latter unrelated tumor suppressor proteins, p16INK4a and p14ARF of which is transcribed in an Alternative Reading Frame (p19ARF in the mouse), which are frequently inactivated in from a separate exon 1b (Duro et al., 1995; Mao et al., human cancer. Both the proapoptotic and cell cycle- 1995; Quelle et al., 1995; Stone et al., 1995). P14ARF is regulatory functions of p14ARF were initially proposed to usually expressed at low levels, but rapid upregulation be strictly dependent on a functional p53/mdm-2 tumor of p14ARF is triggered by various stimuli, that is, suppressor pathway. However, a number of recent reports the expression of cellular or viral oncogenes including have implicated p53-independent mechanisms in the E2F-1, E1A, c-myc, ras, and v-abl (de Stanchina et al., regulation of cell cycle arrest and apoptosis induction by 1998; Palmero et al., 1998; Radfar et al., 1998; Zindy p14ARF. Here, we show that the G1 cell cycle arrest et al., 1998).
  • Human P14arf-Mediated Cell Cycle Arrest Strictly Depends on Intact P53 Signaling Pathways

    Human P14arf-Mediated Cell Cycle Arrest Strictly Depends on Intact P53 Signaling Pathways

    Oncogene (2002) 21, 3207 ± 3212 ã 2002 Nature Publishing Group All rights reserved 0950 ± 9232/02 $25.00 www.nature.com/onc Human p14ARF-mediated cell cycle arrest strictly depends on intact p53 signaling pathways H Oliver Weber1,2, Temesgen Samuel1,3, Pia Rauch1 and Jens Oliver Funk*,1 1Laboratory of Molecular Tumor Biology, Department of Dermatology, University of Erlangen-Nuremberg, 91052 Erlangen, Germany; 2Regulation of Cell Growth Laboratory, National Cancer Institute, Frederick, Maryland, MD 21702-1201, USA The tumor suppressor ARF is transcribed from the INK4a/ 4 and 6 activities, thus leading to decreased phosphor- ARF locus in partly overlapping reading frames with the ylation of RB and to G1 arrest. Cells that are de®cient CDK inhibitor p16Ink4a. ARF is able to antagonize the for RB are resistant to p16Ink4a-mediated cell cycle MDM2-mediated ubiquitination and degradation of p53, arrest (Sherr and Roberts, 1995; Weinberg, 1995). leading to either cell cycle arrest or apoptosis, depending on ARF is also a cell cyle inhibitor. It does not directly the cellular context. However, recent data point to inhibit CDKs but interferes with the function of additional p53-independent functions of mouse p19ARF. MDM2 to destabilize p53. ARF may be activated by Little is known about the dependency of human p14ARF aberrant activation of oncoproteins such as Ras function on p53 and its downstream genes. Therefore, we (Palmero et al., 1998), c-myc (Zindy et al., 1998), analysed the mechanism of p14ARF-induced cell cycle arrest E1A (de Stanchina et al., 1998), Abl (Radfar et al., in several human cell types.
  • Basal P21 Controls Population Heterogeneity in Cycling and Quiescent Cell Cycle States

    Basal P21 Controls Population Heterogeneity in Cycling and Quiescent Cell Cycle States

    Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states K. Wesley Overtona, Sabrina L. Spencerb, William L. Noderera, Tobias Meyerb, and Clifford L. Wanga,1 Departments of aChemical Engineering and bChemical and Systems Biology, Stanford University, Stanford, CA 94305 Edited by Charles S. Peskin, New York University, Manhattan, NY, and approved August 27, 2014 (received for review May 27, 2014) Phenotypic heterogeneity within a population of genetically identical SCF/Skp2 then ubiquitinates p21, targeting it for proteasomal cells is emerging as a common theme in multiple biological systems, degradation (13). Thus, p21 both regulates and, through the ac- including human cell biology and cancer. Using live-cell imaging, flow tion of E3 ubiquitin ligase complexes that target p21, is regulated cytometry, and kinetic modeling, we showed that two states—quies- by active CDK2 bound to Cyclin E. cence and cell cycling—can coexist within an isogenic population of The p21–CDK2 control scheme is an example of a double- human cells and resulted from low basal expression levels of p21, a negative feedback loop. When stochastic gene expression leads Cyclin-dependent kinase (CDK) inhibitor (CKI). We attribute the p21- to fluctuations in factors involved in positive or double-negative dependent heterogeneity in cell cycle activity to double-negative feedback regulation, distinct cellular states within a population feedback regulation involving CDK2, p21, and E3 ubiquitin ligases. can arise (1, 14–18). Because of the role of p21 in the double- In support of this mechanism, analysis of cells at a point before cell negative feedback regulation of cell cycle activity, we hypothesized cycle entry (i.e., before the G1/S transition) revealed a p21–CDK2 axis that p21 controlled population heterogeneity in quiescent and that determines quiescent and cycling cell states.
  • P53 Binding to Nucleosomes Within the P21 Promoter in Vivo Leads To

    P53 Binding to Nucleosomes Within the P21 Promoter in Vivo Leads To

    p53 binding to nucleosomes within the p21 INAUGURAL ARTICLE promoter in vivo leads to nucleosome loss and transcriptional activation Oleg Laptenko, Rachel Beckerman, Ella Freulich, and Carol Prives1 Department of Biological Sciences, Columbia University, New York, NY 10027 This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2008. Contributed by Carol Prives, April 26, 2011 (sent for review November 17, 2010) It is well established that p53 contacts DNA in a sequence- but can be separated by up to 13 bp (9–11). Multiple studies in dependent manner in order to transactivate its myriad target recent years have focused on the interaction of p53 with its genes. Yet little is known about how p53 interacts with its binding cognate binding sites in vivo and in vitro and subsequent gene site/response element (RE) within such genes in vivo in the context transactivation (or transrepression). Here we have examined the of nucleosomal DNA. In this study we demonstrate that both distal nucleosomal status in vivo of p53 binding sites within one of its (5′) and proximal (3′) p53 REs within the promoter of the p21 gene major target genes, p21, before and after induction of p53 and in unstressed HCT116 colon carcinoma cells are localized within a have also determined the extent to which p53 is able to interact region of relatively high nucleosome occupancy. In the absence of with its cognate sites within nucleosomal context. cellular stress, p53 is prebound to both p21 REs within nucleosomal DNA in these cells.
  • 21-Containing C.Yclin Kinases Exist in Oth Acnve and Lnacnve States

    21-Containing C.Yclin Kinases Exist in Oth Acnve and Lnacnve States

    Downloaded from genesdev.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press 21-containing c.yclin kinases exist in oth acnve and lnacnve states Hui Zhang, Gregory J. Hannon, and David Beach Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 USA In normal fibroblasts CDKs exist predominantly in p21/PCNA/cyclin/CDK quaternary complexes, whereas in p53-deficient cells, p21 expression is depressed and the kinases are reduced to a cyclin/CDK binary state, p21 is a universal cyclin kinase inhibitor, but we show here that p21-containing complexes exist in both catalytically active and inactive forms. This finding challenges the current view that active cyclin kinases function only in the binary state and reveals the subtlety with which tumor-suppressor proteins modulate the cell cycle. [Key Words: p21-containing cyclin kinase; cell cycle progression; human fibroblasts; quaternary complex; kinase inhibitor] Received May 12, 1994; revised version accepted June 16, 1994. Much of our current understanding of the regulation of their relative affinities vary with each enzyme (Gu et al. the cell division cycle has emerged from studies of a 1993; Harper et al. 1993; Xiong et al. 1993b). Further- family of protein kinases [cdc2, CDC28, and generically more, several lines of evidence suggest that p21 expres- cyclin-dependent kinase (CDK)] and their inhibitors and sion is regulated by the p53 tumor-suppressor protein activators (for review, see Sherr 1993). A critical step in (E1-Deiry et al. 1993; Xiong et al. 1993b). Thus, cells understanding cell cycle control was the discovery that derived from certain p53-deficient Li-Fraumeni patients CDKs interact with cyclins, proteins that serve as essen- lack p21 associated with cyclin kinases (Xiong et al.
  • P21 Gene Is Inactivated in Metastatic Prostatic Cancer Cell Lines by Promoter Methylation

    P21 Gene Is Inactivated in Metastatic Prostatic Cancer Cell Lines by Promoter Methylation

    Prostate Cancer and Prostatic Diseases (2005) 8, 321–326 & 2005 Nature Publishing Group All rights reserved 1365-7852/05 $30.00 www.nature.com/pcan p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation SRJ Bott1*, M Arya1, RS Kirby1 & M Williamson1 1Prostate Cancer Research Centre, Institute of Urology, University College London, London, UK Introduction: p21WAF1/CIP1 may act as a tumour suppressor gene (TSG) and loss of the p21WAF1/CIP1 gene has been reported in several solid tumours. The aim of this study was to see whether p21WAF1/CIP1 was expressed in metastatic prostate cancer cell lines and to determine if there was methylation of the p21WAF1/CIP1 promoter. Method: PC3, LNCaP and DU145 metastatic prostate cancer cell lines, 1542NP normal prostate, and RD rhabdomyosarcoma cell lines were cultured in the demethylating agent 5-Aza-2 deoxycytidine (5-Aza-CdR). p21WAF1/CIP1 mRNA expression was analysed by RT-PCR. DNA from untreated cell lines was modified with sodium bisulphite and promoter sequencing was performed. Results: p21WAF1/CIP1 was expressed at low or undetectable levels in metastatic prostate cancer cell lines but expression was reactivated by treatment with 5-Aza-CdR. Sequence analysis of the promoter region revealed several sites of methylation at the 50 end of a CpG island in the PC3, LNCaP and DU145 cell line DNA but not in the normal prostate control DNA. Most notably the Sis-inducible element (SEI)-1—a STAT1-binding site, was methylated. Conclusions: In this study, we show that p21WAF1/CIP1 expression in metastatic prostate cancer cell lines is enhanced as a result of demethylation of the DNA.
  • The Potential Tumor Suppressor P73 Differentially Regulates Cellular P53 Target Genes1

    The Potential Tumor Suppressor P73 Differentially Regulates Cellular P53 Target Genes1

    [CANCER RESEARCH 58, 5061-5065. November 15. 1998] Advances in Brief The Potential Tumor Suppressor p73 Differentially Regulates Cellular p53 Target Genes1 Jianhui Zhu,2 Jieyuan Jiang,2 Wenjing Zhou, and Xinbin Chen3 Institute of Molecular Medicine and Genetics, Medical College of Georgia. Augusta, Georgia 30912 Abstract activation and DNA binding domains between p53 and p73, the p53 and p73 signaling pathways leading to tumor suppression are both p73, a potential tumor suppressor, is a p53 homologue. Transient over similar and different. expression of p73 in cells can induce apoptosis and p21, a cellular p53 target gene primarily responsible for p53-dependent cell cycle arrest. To further characterize the role of p73 in tumor suppression, we established Materials and Methods several groups of cell lines that inducibly express p73 under a tetracycline- regulated promoter. By using these cell lines, we found that p73 can Plasmids. cDNAs for p73a. p73ß.and p73«292 (Ref. 3; kindly provided by W. Kaelin) were cloned separately into a tetraeycline-regulated expression induce both cell cycle arrest and apoptosis. We also found that p73 can vector. 10-3, at its Eco RI and Xba I siles, and the resulting plasmids were used activate some but not all of the previously identified p53 cellular target genes. Furthermore, we found that the transcriptional activities of p53, to generate cell lines that inducibly express p73. p73 proteins were tagged at p73a, and p73/3 to induce their common cellular target genes differ among their N-termini with influenza hemagglutinin peptide. one another. These results suggest that p73 is both similar to and different Generation of H1299 Cell Lines that Inducibly Express p73.